The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.
ONA talked to an oncology nurse with Walgreens' cycle management program about how this novel program helps patients and clinicians better manage outpatient oral chemotherapy.
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.
A form of psychotherapy that is intended to relieve distress for dying patients and their families showed great effectiveness in a recent study.
The FDA has approved a portable therapeutic system that can be used at home by adults who have glioblastoma that has recurred or progressed following chemotherapy and radiotherapy.
Standardized posthospitalization care education administered through an Oncology CarePartner Program that addressed the patient's physical and emotional needs was found to improve caregivers' overall well-being, but had no impact on the time spent on caregiving or difficulty with caregiving tasks. That's the result of a study presented at the Oncology Nursing Society 36th Annual Congress.
The CDC and the Healthcare Infection Control Practices Advisory Committee have released new guidelines to help eliminate bloodstream infections associated with intravenous catheters.
Where patients spend their final days has an impact on the quality of life at the end of their life, as well as their caregivers' mental health after their death.
Caregivers are an essential part of patient care. Attentiveness to their concerns is an important part of caring for the patient with cancer.
Increased doses of opioids during end-of-life care at home is safe to relieve pain and suffering, according to a study published in the Journal of Palliative Medicine (2010 Sep;13(9):1079-83).
Outpatient treatment shortens hospital stays and shifts responsibility for patient care onto family members with no medical training.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Encorafenib, Binimetinib Combination Receives FDA Approval for Mutation-Positive Melanoma
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|